Back to Stakeholders

Biotech startup focused on biosynthetic psychedelic compounds and clinical-grade supply, with a product slate spanning psilocybin, DMT, 5-MeO-DMT, and bufotenine.

Manufacturing Snapshot

Psychedelic-Focused Manufacturer

Scope & Capabilities

API ProductionDrug Product Manufacturing

Supply Use Cases

Research UseClinical TrialsCommercial / Licensed Supply

GxP / Compliance

General GxP

Facilities & Access

Eywa positions its platform around biosynthesis of clinical-grade APIs and finished drug products for global research and clinical use.

Manufacturing Details

Supported Substances

Eywa lists clinical-grade psychedelic compounds and compounds portfolio entries for psilocybin, DMT, 5-MeO-DMT, and bufotenine.

Quick Facts

Website
Visit